Irritability in pre-clinical Huntington's disease

Neuropsychologia

Volumn 48, Issue 2, 2010, Pages 549-557

  Klöppel, Stefan ^a,b   Stonnington, Cynthia M ^b,c   Petrovic, Predrag ^b,d   Mobbs, Dean ^b,e   Tüscher, Oliver ^a   Craufurd, David ^f   Tabrizi, Sarah J ^b   Frackowiak, Richard S J ^b,g,h  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c MAYO CLINIC   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e MRC COGNITION AND BRAIN SCIENCES UNIT   (United Kingdom)

^f ST MARY S HOSPITAL   (United Kingdom)

^g LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^h IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

Amygdala; fMRI; Huntington's disease; Irritability; Orbitofrontal cortex

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN RADIOGRAPHY; BRAIN REGION; CONTROLLED STUDY; EMOTIONAL STABILITY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; HUNTINGTON CHOREA; IMAGE ANALYSIS; IRRITABILITY; MALE; NEGATIVE FEEDBACK; NERVE POTENTIAL; ORBITAL CORTEX; POSITIVE FEEDBACK; RISK ASSESSMENT; TASK PERFORMANCE; TIME SERIES ANALYSIS;

ADULT; BRAIN MAPPING; CHI-SQUARE DISTRIBUTION; FEEDBACK, PHYSIOLOGICAL; FEMALE; HUMANS; HUNTINGTON DISEASE; IMAGE PROCESSING, COMPUTER-ASSISTED; IRRITABLE MOOD; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; QUESTIONNAIRES; SEX FACTORS; STATISTICS AS TOPIC; TIME FACTORS;

EID: 72649103644     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2009.10.016     Document Type: Article

References (52)

1. Amodio D.M., and Frith C.D. Meeting of minds: The medial frontal cortex and social cognition. Nature Reviews: Neuroscience 7 (2006) 268-277
2. Anderson A.K., Christoff K., Stappen I., Panitz D., Ghahremani D.G., Glover G., et al. Dissociated neural representations of intensity and valence in human olfaction. Nature Neuroscience 6 (2003) 196-202
3. Anderson S.W., Bechara A., Damasio H., Tranel D., and Damasio A.R. Impairment of social and moral behavior related to early damage in human prefrontal cortex. Nature Neuroscience 2 (1999) 1032-1037
4. Ashburner J., and Friston K.J. Voxel-based morphometry-The methods. Neuroimage 11 (2000) 805-821
5. Barratt E.S., and Patton J.H. Impulsivity: Cognitive, behavioral and psychophysiological correlates. In: Zuckerman M. (Ed). Biological basis of sensation seeking, impulsivity, and anxiety (1983), Lawrence Erlbaum Associates, Hillsdale, NJ 77-122
6. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry 4 (1961) 561-571
7. Best M., Williams J.M., and Coccaro E.F. Evidence for a dysfunctional prefrontal circuit in patients with an impulsive aggressive disorder. Proceedings of the National Academy of Sciences of the United States of America 99 (2002) 8448-8453
8. Blair R.J. Dysfunctions of medial and lateral orbitofrontal cortex in psychopathy. Annals of the New York Academy of Sciences 1121 (2007) 461-479
9. Chatterjee A., Anderson K.E., Moskowitz C.B., Hauser W.A., and Marder K.S. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences 17 (2005) 378-383
10. Coccaro E.F., and Kavoussi R.J. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry 54 (1997) 1081-1088
11. Coccaro E.F., McCloskey M.S., Fitzgerald D.A., and Phan K.L. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biological Psychiatry 62 (2007) 168-178
12. Craufurd D., Thompson J.C., and Snowden J.S. Behavioral changes in Huntington disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 14 (2001) 219-226
13. Davidson R.J., Putnam K.M., and Larson C.L. Dysfunction in the neural circuitry of emotion regulation-A possible prelude to violence. Science 289 (2000) 591-594
14. Deichmann R., Gottfried J.A., Hutton C., and Turner R. Optimized EPI for fMRI studies of the orbitofrontal cortex. Neuroimage 19 (2003) 430-441
15. Deichmann R., Schwarzbauer C., and Turner R. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: Technical implications at 1.5 and 3 T. Neuroimage 21 (2004) 757-767
16. De Marchi N., Daniele F., and Ragone M.A. Fluoxetine in the treatment of Huntington's disease. Psychopharmacology 153 (2001) 264-266
17. Douaud G., Gaura V., Ribeiro M.J., Lethimonnier F., Maroy R., Verny C., et al. Distribution of grey matter atrophy in Huntington's disease patients: A combined ROI-based and voxel-based morphometric study. Neuroimage 32 (2006) 1562-1575
18. Dougherty D.D., Rauch S.L., Deckersbach T., Marci C., Loh R., Shin L.M., et al. Ventromedial prefrontal cortex and amygdala dysfunction during an anger induction positron emission tomography study in patients with major depressive disorder with anger attacks. Archives of General Psychiatry 61 (2004) 795-804
19. Eickhoff S.B., Stephan K.E., Mohlberg H., Grefkes C., Fink G.R., Amunts K., et al. A new SPM toolbox for combining probabilistic cytoarchitectonic maps and functional imaging data. Neuroimage 25 (2005) 1325-1335
20. Folstein S.E., Chase G.A., Wahl W.E., McDonnell A.M., and Folstein M.F. Huntington disease in Maryland: Clinical aspects of racial variation. American Journal of Human Genetics 41 (1987) 168-179
21. Friston K.J., Frith C.D., Turner R., and Frackowiak R.S. Characterizing evoked hemodynamics with fMRI. Neuroimage 2 (1995) 157-165
22. Gallagher H.L., Jack A.I., Roepstorff A., and Frith C.D. Imaging the intentional stance in a competitive game. Neuroimage 16 (2002) 814-821
23. Gray J.M., Young A.W., Barker W.A., Curtis A., and Gibson D. Impaired recognition of disgust in Huntington's disease gene carriers. Brain 120 Pt 11 (1997) 2029-2038
24. Hamilton J.M., Salmon D.P., Corey-Bloom J., Gamst A., Paulsen J.S., Jerkins S., et al. Behavioural abnormalities contribute to functional decline in Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 74 (2003) 120-122
25. HD Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72 (1993) 971-983
26. Hoth K.F., Paulsen J.S., Moser D.J., Tranel D., Clark L.A., and Bechara A. Patients with Huntington's disease have impaired awareness of cognitive, emotional, and functional abilities. Journal of Clinical and Experimental Neuropsychology 29 (2007) 365-376
27. Hutton C., Bork A., Josephs O., Deichmann R., Ashburner J., and Turner R. Image distortion correction in fMRI: A quantitative evaluation. Neuroimage 16 (2002) 217-240
28. Johnson S.A., Stout J.C., Solomon A.C., Langbehn D.R., Aylward E.H., Cruce C.B., et al. Beyond disgust: Impaired recognition of negative emotions prior to diagnosis in Huntington's disease. Brain 130 (2007) 1732-1744
29. Julien C.L., Thompson J.C., Wild S., Yardumian P., Snowden J.S., Turner G., et al. Psychiatric disorders in preclinical Huntington's disease. Journal of Neurology, Neurosurgery and Psychiatry 78 (2007) 939-943
30. Kloppel S., Draganski B., Siebner H.R., Tabrizi S.J., Weiller C., and Frackowiak R.S. Functional compensation of motor function in pre-symptomatic Huntington's disease. Brain 132 (2009) 1624-1632
31. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., and Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clinical Genetics 65 (2004) 267-277
32. Mann D.M., Oliver R., and Snowden J.S. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy. Acta Neuropathologica 85 (1993) 553-559
33. Nelson H.E., and Willison J. The national adult reading test (1991), NFER-Nelson, Windsor, UK
34. Paleacu D., Anca M., and Giladi N. Olanzapine in Huntington's disease. Acta Neurologica Scandinavica 105 (2002) 441-444
35. Paradiso S., Turner B.M., Paulsen J.S., Jorge R., Ponto L.L., and Robinson R.G. Neural bases of dysphoria in early Huntington's disease. Psychiatry Research 162 (2008) 73-87
36. Pavese N., Andrews T.C., Brooks D.J., Ho A.K., Rosser A.E., Barker R.A., et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A PET study. Brain 126 (2003) 1127-1135
37. Ranen N.G., Lipsey J.R., Treisman G., and Ross C.A. Sertraline in the treatment of severe aggressiveness in Huntington's disease. Journal of Neuropsychiatry and Clinical Neurosciences 8 (1996) 338-340
38. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., et al. Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology 55 (2004) 879-883
39. Rempel-Clower N.L. Role of orbitofrontal cortex connections in emotion. Annals of the New York Academy of Sciences 1121 (2007) 72-86
40. Rilling J.K., Sanfey A.G., Aronson J.A., Nystrom L.E., and Cohen J.D. The neural correlates of theory of mind within interpersonal interactions. Neuroimage 22 (2004) 1694-1703
41. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: An MRI-based morphometric analysis. Neurology 60 (2003) 1615-1620
42. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 58 (2002) 695-701
43. Siever L.J. Neurobiology of aggression and violence. American Journal of Psychiatry 165 (2008) 429-442
44. Snaith R.P., Constantopoulos A.A., Jardine M.Y., and McGuffin P. A clinical scale for the self-assessment of irritability. British Journal of Psychiatry 132 (1978) 164-171
45. Snowden J.S., Gibbons Z.C., Blackshaw A., Doubleday E., Thompson J., Craufurd D., et al. Social cognition in frontotemporal dementia and Huntington's disease. Neuropsychologia 41 (2003) 688-701
46. Spielberger C.D. Manual for the State-Trait Anger Expression Scale (STAXI) (1988), Psychological Assessment Resources, Odessa, FL
47. Squitieri F., Cannella M., Piorcellini A., Brusa L., Simonelli M., and Ruggieri S. Short-term effects of olanzapine in Huntington disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 14 (2001) 69-72
48. Tebartz van Elst L., Woermann F.G., Lemieux L., Thompson P.J., and Trimble M.R. Affective aggression in patients with temporal lobe epilepsy: A quantitative MRI study of the amygdala. Brain 123 Pt 2 (2000) 234-243
49. Urry H.L., van Reekum C.M., Johnstone T., Kalin N.H., Thurow M.E., Schaefer H.S., et al. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. Journal of Neuroscience 26 (2006) 4415-4425
50. Wheelock V.L., Tempkin T., Marder K., Nance M., Myers R.H., Zhao H., et al. Predictors of nursing home placement in Huntington disease. Neurology 60 (2003) 998-1001
51. Williams L.M., Das P., Liddell B.J., Kemp A.H., Rennie C.J., and Gordon E. Mode of functional connectivity in amygdala pathways dissociates level of awareness for signals of fear. Journal of Neuroscience 26 (2006) 9264-9271
52. Wolf R.C., Vasic N., Schonfeldt-Lecuona C., Landwehrmeyer G.B., and Ecker D. Dorsolateral prefrontal cortex dysfunction in presymptomatic Huntington's disease: Evidence from event-related fMRI. Brain 130 (2007) 2845-2857